Beleaguered Abbott Laboratories is under fire again with news that the Food and Drug Administration is looking at a new complaint about a baby’s death after taking the baby substitute. The child died in January, according to Wall Street Journal, but the FDA says they received a consumer complaint on June 10 and have started an investigation that is in its early stages. A spokesman for Abbott told the Journal that there was no evidence linking the death to the company’s formulas, which include Similac. The company is already under heavy criticism from both sides of the aisle for what lawmakers see as its slow response to problems at the Sturgis, Michigan plant, which led to a shutdown and a worsening shortage of baby replacements across the country. The FDA previously announced that two babies had died among four who contracted a bacterial infection after eating formula made at the plant.
Read it on Wall Street Journal